Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Unilateral Cutaneous Ureterostomy - Long Term Follow up (ureterostomy)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00546208
First received: October 17, 2007
Last updated: March 13, 2008
Last verified: March 2008
  Purpose

This observational study is aimed at exploring bladder function following temporary unilateral low loop cutaneous ureterostomy carried out in newborns suffering from severe congenital hydro-ureteronephrosis


Condition
Bladder Function

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Bladder Function Following Temporary Unilateral Cutaneous Ureterostomy - Long Term Follow up

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 30
Study Start Date: February 2008
Groups/Cohorts
1
adolescents and young adults who underwent, as newborns, unilateral low loop cutaneous ureterostomy for severe bilateral hydro-ureteronephrosis, and that, afterwards, underwent stomal closure

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

adolescents and adults who had been operated in our institution for severe bilateral congenital hydro-ureteronephrosis

Criteria

Inclusion Criteria:

  • Living patients
  • Bilateral functioning kidneys
  • Unilateral ureteral cutaneous diversion

Exclusion Criteria:

  • Dead patients
  • Single kidney
  • High percutaneous ureteral diversion (e.g: cutaneous pyelostomies, bilateral cutaneous urinary diversion)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00546208

Contacts
Contact: Dorit E Zilberman, MD +97235302231 dorit.zilberman@sheba.health.gov.il

Locations
Israel
The Chaim Sheba Medical Center, Tel Hashomer Recruiting
Ramat Gan, Israel, 52621
Contact: Dorit E Zilberman, MD    +973-3-5302231    dorit.zilberman@sheba.health.gov.il   
Sub-Investigator: Yoram Mor, MD         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Dorit E Zilberman, MD The Chaim Sheba Medical Center
  More Information

No publications provided

Responsible Party: Dorit Zilberman, Urology Department, Chaim Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00546208     History of Changes
Other Study ID Numbers: SHEBA-07-4838-DZ-CTIL
Study First Received: October 17, 2007
Last Updated: March 13, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
bladder function
cutaneous ureterostomy
hydronephrosis

ClinicalTrials.gov processed this record on November 20, 2014